HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$24.31
Day range
$23.90 - $24.66
Year range
$15.47 - $27.22
Market cap
1.07B USD
Avg Volume
570.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.82M | 63.78% |
Net income | -35.96M | -74.30% |
Net profit margin | — | — |
Earnings per share | -0.78 | -27.87% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 312.82M | 42.93% |
Total assets | 333.17M | 21.18% |
Total liabilities | 25.94M | 50.08% |
Total equity | 307.22M | — |
Shares outstanding | 44.20M | — |
Price to book | 3.36 | — |
Return on assets | -29.42% | — |
Return on capital | -31.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -35.96M | -74.30% |
Cash from operations | -30.66M | -89.81% |
Cash from investing | -71.20M | 63.01% |
Cash from financing | 34.72M | 63,036.36% |
Net change in cash | -67.13M | 67.81% |
Free cash flow | -15.74M | -52.34% |
About
Founded
2021
Headquarters
Website
Employees
77
